Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
205.50    -4.50 (-2.14%)
Bid:
205.00
Ask:
206.50
Spread: 1.50 (0.732%)
Market Cap: £547.02m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

CEO Succession

6 Mar 2019 07:00

RNS Number : 9473R
Costain Group PLC
06 March 2019
Β 

Costain Group PLC

("Costain" or "the Group" or "the Company")

Β 

Β 

CEO SuccessionΒ 

Β 

Costain today announces that Andrew Wyllie CBE, after 14 years as CEO of the Company, is retiring in order to pursue a non-executive career. He recently took up the presidency of the Institution of Civil Engineers and is a non-executive director of Yorkshire Water Services.

Β 

Alex Vaughan, currently managing director of the Group's natural resources division, will be appointed as CEO with effect from the conclusion of the Company's AGM on 7 May 2019. The appointment of Alex is in accordance with the Board's succession plan which included an extensive internal and external search process.

Β 

Alex joined Costain in 1992, was appointed to the executive Board in 2006 and has played a leading role in Costain's transformation into a smart infrastructure solutions business through his leadership of the development and growth of the Group's consultancy and technology services. In his current role, Alex has delivered significant growth in profit and margin in the natural resources division.

Β 

He is a qualified chartered quantity surveyor, has worked on infrastructure projects in the UK and internationally and, additionally at Costain, has held various corporate roles across HR, strategy, M&A and corporate development.

Β 

In order to effect an orderly handover, Andrew will remain as CEO and on the Board until 7 May 2019 and will remain an employee of the Company until 6 September 2019.

Β 

Dr Paul Golby CBE, chair commented:

Β 

"I would like to thank Andrew for everything that he has done for the business and to wish him and his family well for the future. Andrew can feel extremely proud of what he has achieved at Costain. He leaves the Group in good health, the result of the growth strategy which he and his colleagues have been implementing for the last fourteen years. We are delighted that Alex will be taking over. He has played a major role in the development of the Group and the implementation of its strategy, and has the expertise and ambition to deliver the future growth of the business."

Β 

Β Andrew Wyllie CBE, commented:

Β 

"I have thoroughly enjoyed the past fourteen years and would like to thank my colleagues for their support and commitment. Costain is a great business with a great future ahead of it."

Β 

Alex Vaughan commented:

Β 

"I am delighted to have been appointed CEO and very much look forward to leading the business and continuing our strategy as we enter a new era of opportunity for Costain."

Β 

Β 

Β 

Β Enquiries:

Β 

Costain

Tel: 01628 842 444

Carolyn Rich, Investor Relations Director

Β 

Sara Lipscombe, Group Communications Director

Β 

Β 

Β 

Β 

Instinctif Partners

Tel: 0207 457 2020

Mark Garraway

Β 

James Gray

Β 

Β 

Notes:

Listing Rule 9.6.13R

The Company confirms that there are no disclosures to be made in connection with Mr Vaughan's appointment in accordance with Listing Rule 9.6.13R.Β 

Information regarding Mr Wyllie

Information on payments to be made to Andrew Wyllie after he ceases to be a director, which the Company is required to make available under s430(2B) of the Companies Act 2006, can be accessed via the Investors section on www.costain.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOACKPDNFBKDBNK
Date   Source Headline
25th Jun 202610:25 amRNSDirector/PDMR Shareholding
24th Jun 202610:30 amRNSTransaction in Own Shares
23rd Jun 202610:11 amRNSDirector/PDMR Shareholding
18th Jun 202611:46 amRNSDirector/PDMR Shareholding
18th Jun 20267:00 amRNS-RCostain wins West Winch Housing Road contract
17th Jun 202610:30 amRNSTransaction in Own Shares
10th Jun 20269:27 amRNSTransaction in Own Shares
9th Jun 20263:25 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSCostain wins place on £700m TfL framework
3rd Jun 202610:30 amRNSTransaction in Own Shares
1st Jun 202610:31 amRNSTotal Voting Rights
27th May 20269:34 amRNSTransaction in Own Shares
22nd May 20261:00 pmRNSDirector/PDMR Shareholding
20th May 20269:55 amRNSTransaction in Own Shares
18th May 20261:51 pmRNSAdditional Listing
18th May 20269:39 amRNSDirector Declaration
14th May 20264:28 pmRNSResult of AGM
14th May 20267:00 amRNSAGM Trading Update
13th May 20265:14 pmRNSHolding(s) in Company
13th May 202610:19 amRNSTransaction in Own Shares
12th May 20264:01 pmRNSHolding(s) in Company
6th May 20269:35 amRNSTransaction in Own Shares
5th May 20262:08 pmRNSDirector/PDMR Shareholding
1st May 20264:08 pmRNSScrip Dividend Reference Price - Replacement
1st May 20269:08 amRNSTotal Voting Rights
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
29th Apr 202610:14 amRNSTransaction in Own Shares
27th Apr 202612:27 pmRNSScrip Dividend Reference Price
22nd Apr 20265:06 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:48 amRNSTransaction in Own Shares
21st Apr 20265:15 pmRNSHolding(s) in Company
16th Apr 20264:59 pmRNSHolding(s) in Company
15th Apr 20263:16 pmRNSTransaction in Own Shares
15th Apr 20263:05 pmRNSDirector/PDMR Shareholding
14th Apr 20263:29 pmRNSDirector Declaration
13th Apr 202611:20 amRNSDirector/PDMR Shareholding
8th Apr 202610:30 amRNSTransaction in Own Shares
2nd Apr 202611:19 amRNSAnnual Financial Report
1st Apr 202610:30 amRNSTransaction in Own Shares
1st Apr 20269:30 amRNSDirector/PDMR Shareholding
1st Apr 20268:59 amRNSTotal Voting Rights
27th Mar 20263:35 pmRNSAdditional Listing
25th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNS-RCostain Secures c.£45m Contract with Severn Trent
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
4th Mar 20268:27 amRNSDirectorate change
3rd Mar 202610:57 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.